Viking Therapeutics Inc.

Viking Therapeutics Inc. annual/quarterly operating income history and growth rate from 2014 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Viking Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -164.1 M, a 195.89% increase year-over-year.
• Viking Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -392.7 M, a 197.64% increase year-over-year.
• Viking Therapeutics Inc. annual operating income for 2025 was -393.3 M, a 160.63% increase from 2024.
• Viking Therapeutics Inc. annual operating income for 2024 was -150.9 M, a 49.68% increase from 2023.
• Viking Therapeutics Inc. annual operating income for 2023 was -100.8 M, a 43.31% increase from 2022.
• Viking Therapeutics Inc. annual operating income for 2022 was -70.4 M.